Literature DB >> 12366506

Bactericidal/permeability-increasing protein inhibits endotoxin-induced vascular nitric oxide synthesis.

C D Ciornei1, A Egesten, M Engström, K Törnebrandt, M Bodelsson.   

Abstract

BACKGROUND: Endotoxin (lipopolysaccharide, LPS) up-regulates inducible nitric oxide synthase (iNOS) in blood vessels during septic shock. This promotes the production of nitric oxide (NO), leading to dilation of the vessels. The aim of the study was to investigate the effects of the LPS-binding endogenous antibiotic bactericidal/permeability-increasing protein (BPI) on the action of LPS on the blood vessels wall and to identify possible influence on underlying NO-related mechanisms.
METHODS: Isolated segments of rat thoracic aorta and cultured primary smooth muscle cells were incubated for 5-48 h in the presence of the following combinations of compounds: (a) LPS; (b) interleukin-1beta (IL-1beta); (c) BPI; (d) BPI + LPS; (e) BPI + IL-1beta or (f) neither BPI, LPS nor IL-1beta (control). After incubation of intact segments, we measured smooth muscle contraction in response to phenylephrine and accumulation of the NO end products nitrate and nitrite in surrounding medium. Western blot was used to assess the levels of inducible nitric oxide synthase (iNOS) in cultured cells.
RESULTS: Both LPS and IL-1beta decreased contractility and increased NO production, as well as iNOS. Co-incubation with BPI attenuated all the effects of LPS but only the effects of prolonged exposure to IL-1beta in cultured cells.
CONCLUSION: We conclude that BPI attenuates the LPS-induced changes in vascular reactivity by inhibiting the expression of iNOS resulting in decreased NO formation and restored responsiveness to vasoconstrictors. The data suggest that BPI can prevent circulatory disturbances during Gram-negative sepsis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12366506     DOI: 10.1034/j.1399-6576.2002.460909.x

Source DB:  PubMed          Journal:  Acta Anaesthesiol Scand        ISSN: 0001-5172            Impact factor:   2.105


  5 in total

1.  In silico identification and biological evaluation of antimicrobial peptides based on human cathelicidin LL-37.

Authors:  Thorgerdur Sigurdardottir; Pia Andersson; Mina Davoudi; Martin Malmsten; Artur Schmidtchen; Mikael Bodelsson
Journal:  Antimicrob Agents Chemother       Date:  2006-09       Impact factor: 5.191

2.  Immunomodulatory activities of small host defense peptides.

Authors:  Dawn M E Bowdish; Donald J Davidson; Monisha G Scott; Robert E W Hancock
Journal:  Antimicrob Agents Chemother       Date:  2005-05       Impact factor: 5.191

3.  Human antimicrobial peptide LL-37 is present in atherosclerotic plaques and induces death of vascular smooth muscle cells: a laboratory study.

Authors:  Cristina D Ciornei; Hans Tapper; Anders Bjartell; Nils H Sternby; Mikael Bodelsson
Journal:  BMC Cardiovasc Disord       Date:  2006-12-20       Impact factor: 2.298

4.  Bactericidal/permeability-increasing protein originates in both the testis and the epididymis and localizes in mouse spermatozoa.

Authors:  Zhong-Ping Zhou; Xiao-Yu Xia; Qiang-Su Guo; Chen Xu
Journal:  Asian J Androl       Date:  2014 Mar-Apr       Impact factor: 3.285

Review 5.  Male infertility-related molecules involved in sperm-oocyte fusion.

Authors:  Lisha Mou; Ni Xie
Journal:  J Reprod Dev       Date:  2016-12-01       Impact factor: 2.214

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.